Constitutive activity at the cannabinoid CB(1) receptor and behavioral responses.
Hanlon
Katherine E
KE
Department of Pharmacology, University of Arizona, Tucson, Arizona, USA.
Vanderah
Todd W
TW
D000818:Animals; D063386:Cannabinoid Receptor Agonists; D063387:Cannabinoid Receptor Antagonists; D002186:Cannabinoids / Q000008:administration & dosage / Q000627:therapeutic use; D004333:Drug Administration Routes; D006801:Humans; D007249:Inflammation / Q000188:drug therapy / Q000378:metabolism / Q000503:physiopathology; D051379:Mice; D009369:Neoplasms / Q000188:drug therapy / Q000378:metabolism / Q000503:physiopathology; D009437:Neuralgia / Q000188:drug therapy / Q000378:metabolism; D010146:Pain / Q000378:metabolism; D051381:Rats; D043882:Receptors, Cannabinoid / Q000378:metabolism*
D063386:Cannabinoid Receptor Agonists; D063387:Cannabinoid Receptor Antagonists; D002186:Cannabinoids; D043882:Receptors, Cannabinoid